# John Wiley & Sons, Inc.: financial statements, quarterly

WLY · NYSE · CIK 107140 · [Communication](/sectors/communication.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/wly.md) · [Financials](/companies/wly/financials.md) · [Filings](/companies/wly/filings.md) · [Insiders](/companies/wly/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wly/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [493](/filings/0000107140-24-000237.md) | [461](/filings/0000107140-25-000018.md) | [468 d](/filings/0001628280-26-045111.md) | [404](/filings/0000107140-25-000155.md) | [427](/filings/0000107140-25-000198.md) | [405](/filings/0000107140-26-000012.md) | [443 d](/filings/0001628280-26-045111.md) | [397](/filings/0001628280-26-060632.md) | [422](/filings/0000107140-25-000198.md) | [410](/filings/0000107140-26-000012.md) | [448 d](/filings/0001628280-26-045111.md) | [386](/filings/0001628280-26-060632.md) |
| Cost of revenue | $m | [156](/filings/0000107140-24-000237.md) | [144](/filings/0000107140-25-000018.md) | [123 d](/filings/0001628280-26-045111.md) | [109](/filings/0000107140-25-000155.md) | [107](/filings/0000107140-25-000198.md) | [104](/filings/0000107140-26-000012.md) | [111 d](/filings/0001628280-26-045111.md) | [109](/filings/0001628280-26-060632.md) | [104](/filings/0000107140-25-000198.md) | [108](/filings/0000107140-26-000012.md) | [110 d](/filings/0001628280-26-045111.md) | [101](/filings/0001628280-26-060632.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [252](/filings/0000107140-24-000237.md) | [253](/filings/0000107140-25-000018.md) | [252 d](/filings/0001628280-26-045111.md) | [249](/filings/0000107140-25-000155.md) | [239](/filings/0000107140-25-000198.md) | [230](/filings/0000107140-26-000012.md) | [230 d](/filings/0001628280-26-045111.md) | [240](/filings/0001628280-26-060632.md) | [225](/filings/0000107140-25-000198.md) | [219](/filings/0000107140-26-000012.md) | [211 d](/filings/0001628280-26-045111.md) | [239](/filings/0001628280-26-060632.md) |
| Operating income | $m | [46.2](/filings/0000107140-24-000237.md) | [(46.4)](/filings/0000107140-25-000018.md) | [68.8 d](/filings/0001628280-26-045111.md) | [29.0](/filings/0000107140-25-000155.md) | [64.1](/filings/0000107140-25-000198.md) | [51.8](/filings/0000107140-26-000012.md) | [76.5 d](/filings/0001628280-26-045111.md) | [31.0](/filings/0001628280-26-060632.md) | [73.0](/filings/0000107140-25-000198.md) | [62.8](/filings/0000107140-26-000012.md) | [110 d](/filings/0001628280-26-045111.md) | [2.9](/filings/0001628280-26-060632.md) |
| Interest expense | $m | [12.9](/filings/0000107140-23-000239.md) | [13.3](/filings/0000107140-24-000029.md) | [11.4 d](/filings/0000107140-24-000114.md) | [12.8](/filings/0000107140-25-000155.md) | [14.5](/filings/0000107140-25-000198.md) | [14.0](/filings/0000107140-26-000012.md) | [11.3 d](/filings/0001628280-26-045111.md) | [11.0](/filings/0001628280-26-060632.md) | [11.7](/filings/0000107140-25-000198.md) | [11.5](/filings/0000107140-26-000012.md) | [9.6 d](/filings/0001628280-26-045111.md) | [13.9](/filings/0001628280-26-060632.md) |
| Income tax | $m | [(2.6)](/filings/0000107140-24-000237.md) | [1.6](/filings/0000107140-25-000018.md) | [28.7 d](/filings/0001628280-26-045111.md) | [24.4](/filings/0000107140-25-000155.md) | [8.5](/filings/0000107140-25-000198.md) | [41.6](/filings/0000107140-26-000012.md) | [(15.8) d](/filings/0001628280-26-045111.md) | [6.0](/filings/0001628280-26-060632.md) | [13.1](/filings/0000107140-25-000198.md) | [14.7](/filings/0000107140-26-000012.md) | [(40.4) d](/filings/0001628280-26-045111.md) | [(0.9)](/filings/0001628280-26-060632.md) |
| Net income | $m | [(19.4)](/filings/0000107140-24-000237.md) | [(114)](/filings/0000107140-25-000018.md) | [25.3 d](/filings/0001628280-26-045111.md) | [(1.4)](/filings/0000107140-25-000155.md) | [40.5](/filings/0000107140-25-000198.md) | [(23.0)](/filings/0000107140-26-000012.md) | [68.1 d](/filings/0001628280-26-045111.md) | [11.7](/filings/0001628280-26-060632.md) | [44.9](/filings/0000107140-25-000198.md) | [29.7](/filings/0000107140-26-000012.md) | [135 d](/filings/0001628280-26-045111.md) | [(11.7)](/filings/0001628280-26-060632.md) |
| Diluted EPS | $ per share | [(0.35)](/filings/0000107140-24-000237.md) | [(2.08)](/filings/0000107140-25-000018.md) | not reported | [(0.03)](/filings/0000107140-25-000155.md) | [0.74](/filings/0000107140-25-000198.md) | [(0.43)](/filings/0000107140-26-000012.md) | not reported | [0.22](/filings/0001628280-26-060632.md) | [0.84](/filings/0000107140-25-000198.md) | [0.56](/filings/0000107140-26-000012.md) | not reported | [(0.23)](/filings/0001628280-26-060632.md) |
| Basic EPS | $ per share | [(0.35)](/filings/0000107140-24-000237.md) | [(2.08)](/filings/0000107140-25-000018.md) | not reported | [(0.03)](/filings/0000107140-25-000155.md) | [0.75](/filings/0000107140-25-000198.md) | [(0.43)](/filings/0000107140-26-000012.md) | not reported | [0.22](/filings/0001628280-26-060632.md) | [0.85](/filings/0000107140-25-000198.md) | [0.57](/filings/0000107140-26-000012.md) | not reported | [(0.23)](/filings/0001628280-26-060632.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [83.2](/filings/0000107140-23-000239.md) | [93.1](/filings/0000107140-24-000029.md) | [83.2](/filings/0000107140-25-000081.md) | [82.5](/filings/0000107140-24-000189.md) | [75.5](/filings/0000107140-24-000237.md) | [105](/filings/0000107140-25-000018.md) | [85.9](/filings/0001628280-26-045111.md) | [81.9](/filings/0000107140-25-000155.md) | [67.4](/filings/0000107140-25-000198.md) | [95.1](/filings/0000107140-26-000012.md) | [75.6](/filings/0001628280-26-060632.md) | [106](/filings/0001628280-26-060632.md) |
| Current assets | $m | [426](/filings/0000107140-23-000239.md) | [384](/filings/0000107140-24-000029.md) | [454](/filings/0000107140-25-000081.md) | [393](/filings/0000107140-24-000189.md) | [370](/filings/0000107140-24-000237.md) | [395](/filings/0000107140-25-000018.md) | [440](/filings/0001628280-26-045111.md) | [420](/filings/0000107140-25-000155.md) | [381](/filings/0000107140-25-000198.md) | [411](/filings/0000107140-26-000012.md) | [420](/filings/0001628280-26-060632.md) | [438](/filings/0001628280-26-060632.md) |
| Total assets | $m | [2,779](/filings/0000107140-23-000239.md) | [2,707](/filings/0000107140-24-000029.md) | [2,725](/filings/0000107140-25-000081.md) | [2,652](/filings/0000107140-24-000189.md) | [2,609](/filings/0000107140-24-000237.md) | [2,600](/filings/0000107140-25-000018.md) | [2,691](/filings/0001628280-26-045111.md) | [2,524](/filings/0000107140-25-000155.md) | [2,467](/filings/0000107140-25-000198.md) | [2,561](/filings/0000107140-26-000012.md) | [2,592](/filings/0001628280-26-060632.md) | [3,132](/filings/0001628280-26-060632.md) |
| Current liabilities | $m | [610](/filings/0000107140-23-000239.md) | [712](/filings/0000107140-24-000029.md) | [873](/filings/0000107140-25-000081.md) | [689](/filings/0000107140-24-000189.md) | [561](/filings/0000107140-24-000237.md) | [717](/filings/0000107140-25-000018.md) | [821](/filings/0001628280-26-045111.md) | [649](/filings/0000107140-25-000155.md) | [540](/filings/0000107140-25-000198.md) | [692](/filings/0000107140-26-000012.md) | [779](/filings/0001628280-26-060632.md) | [689](/filings/0001628280-26-060632.md) |
| Total liabilities | $m | [1,912](/filings/0000107140-23-000239.md) | [1,959](/filings/0000107140-24-000029.md) | [1,986](/filings/0000107140-25-000081.md) | [1,938](/filings/0000107140-24-000189.md) | [1,854](/filings/0000107140-24-000237.md) | [1,915](/filings/0000107140-25-000018.md) | [1,939](/filings/0001628280-26-045111.md) | [1,791](/filings/0000107140-25-000155.md) | [1,727](/filings/0000107140-25-000198.md) | [1,811](/filings/0000107140-26-000012.md) | [1,744](/filings/0001628280-26-060632.md) | [2,335](/filings/0001628280-26-060632.md) |
| Long-term debt | $m | [938](/filings/0000107140-23-000239.md) | [901](/filings/0000107140-24-000029.md) | [767](/filings/0000107140-25-000081.md) | [910](/filings/0000107140-24-000189.md) | [951](/filings/0000107140-24-000237.md) | [877](/filings/0000107140-25-000018.md) | [789](/filings/0001628280-26-045111.md) | [818](/filings/0000107140-25-000155.md) | [862](/filings/0000107140-25-000198.md) | [796](/filings/0000107140-26-000012.md) | [671](/filings/0001628280-26-060632.md) | [1,278](/filings/0001628280-26-060632.md) |
| Current portion of debt | $m | [5.0](/filings/0000107140-23-000239.md) | [6.3](/filings/0000107140-24-000029.md) | [7.5](/filings/0000107140-25-000081.md) | [8.8](/filings/0000107140-24-000189.md) | [10.0](/filings/0000107140-24-000237.md) | [10.0](/filings/0000107140-25-000018.md) | [10.0](/filings/0001628280-26-045111.md) | [10.0](/filings/0000107140-25-000155.md) | [10.0](/filings/0000107140-25-000198.md) | [11.3](/filings/0000107140-26-000012.md) | [12.5](/filings/0001628280-26-060632.md) | [13.8](/filings/0001628280-26-060632.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [867](/filings/0000107140-25-000018.md) | [748](/filings/0000107140-25-000018.md) | [740](/filings/0001628280-26-045111.md) | [714](/filings/0000107140-25-000198.md) | [755](/filings/0000107140-26-000012.md) | [685](/filings/0000107140-26-000012.md) | [752](/filings/0001628280-26-060632.md) | [733](/filings/0001628280-26-060632.md) | [740](/filings/0000107140-26-000012.md) | [750](/filings/0000107140-26-000012.md) | [848](/filings/0001628280-26-060632.md) | [797](/filings/0001628280-26-060632.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.2) d](/filings/0000107140-24-000237.md) | [108 d](/filings/0000107140-25-000018.md) | [183 d](/filings/0001628280-26-045111.md) | [(88.7)](/filings/0000107140-25-000155.md) | [(5.3) d](/filings/0000107140-25-000198.md) | [146 d](/filings/0000107140-26-000012.md) | [150 d](/filings/0001628280-26-045111.md) | [(85.0)](/filings/0001628280-26-060632.md) | [8.5 d](/filings/0000107140-25-000198.md) | [180 d](/filings/0000107140-26-000012.md) | [157 d](/filings/0001628280-26-045111.md) | [(55.3)](/filings/0001628280-26-060632.md) |
| Capital expenditure | $m | [20.2 d](/filings/0000107140-24-000237.md) | [17.0 d](/filings/0000107140-25-000018.md) | [18.8 d](/filings/0001628280-26-045111.md) | [14.5](/filings/0000107140-25-000155.md) | [14.5 d](/filings/0000107140-25-000198.md) | [13.3 d](/filings/0000107140-26-000012.md) | [19.1 d](/filings/0001628280-26-045111.md) | [12.0](/filings/0001628280-26-060632.md) | [13.1 d](/filings/0000107140-25-000198.md) | [12.9 d](/filings/0000107140-26-000012.md) | [13.2 d](/filings/0001628280-26-045111.md) | [11.2](/filings/0001628280-26-060632.md) |
| Dividends paid | $m | [19.3 d](/filings/0000107140-24-000237.md) | [19.2 d](/filings/0000107140-25-000018.md) | [19.1 d](/filings/0001628280-26-045111.md) | [19.2](/filings/0000107140-25-000155.md) | [19.1 d](/filings/0000107140-25-000198.md) | [19.0 d](/filings/0000107140-26-000012.md) | [18.9 d](/filings/0001628280-26-045111.md) | [19.0](/filings/0001628280-26-060632.md) | [18.8 d](/filings/0000107140-25-000198.md) | [18.5 d](/filings/0000107140-26-000012.md) | [18.1 d](/filings/0001628280-26-045111.md) | [18.2](/filings/0001628280-26-060632.md) |
| Share repurchases | $m | [12.5 d](/filings/0000107140-24-000237.md) | [6.5 d](/filings/0000107140-25-000018.md) | [16.1 d](/filings/0001628280-26-045111.md) | [12.5](/filings/0000107140-25-000155.md) | [12.9 d](/filings/0000107140-25-000198.md) | [10.0 d](/filings/0000107140-26-000012.md) | [25.0 d](/filings/0001628280-26-045111.md) | [13.5](/filings/0001628280-26-060632.md) | [21.6 d](/filings/0000107140-25-000198.md) | [34.9 d](/filings/0000107140-26-000012.md) | [30.1 d](/filings/0001628280-26-045111.md) | [15.2](/filings/0001628280-26-060632.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-31) | Q3 FY2023 (2023-01-31) | Q1 FY2024 (2023-07-31) | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [56.2](/filings/0000107140-23-000239.md) | [55.5](/filings/0000107140-24-000029.md) | [55.3](/filings/0000107140-24-000189.md) | [55.1](/filings/0000107140-24-000237.md) | [54.8](/filings/0000107140-25-000018.md) | [54.4](/filings/0000107140-25-000155.md) | [54.9](/filings/0000107140-25-000198.md) | [54.0](/filings/0000107140-26-000012.md) | [54.0](/filings/0001628280-26-060632.md) | [53.5](/filings/0000107140-25-000198.md) | [52.7](/filings/0000107140-26-000012.md) | [50.8](/filings/0001628280-26-060632.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 60,884,591 at 2011-05-31, from the cover of the [10-K filed 2011-06-24](/filings/0000107140-11-000016.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.